Home
About
Overview
Sharing Data
ORCID
Help
History (2)
12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice.
Inhibition of the Eukaryotic Initiation Factor-2-a Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibition of the Eukaryotic Initiation Factor-2-a Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice.
Inhibition of the Eukaryotic Initiation Factor-2-a Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice. bioRxiv. 2024 Jun 03.
View in:
PubMed
authors with profiles
Scott Oakes
Sarah Tersey